BISHKEK, Kyrgyzstan, September 24. The share of industry in Kyrgyzstan's GDP amounted to 42 percent, or 437.1 million soms, in the period from January through August 2025.
The data obtained by Trend from the country's National Statistic Committee indicates that this marks an 11.5 percent increase compared to the same period last year. The production of basic metals and finished metal products, excluding machinery and equipment, accounts for 44 percent of the Kyrgyz industry.
The growth in industrial output was supported by a surge in pharmaceutical production, which expanded 2.2 times year-on-year. Significant gains were also recorded in food products, including beverages and tobacco (up 44.4 percent), wood, paper, and printing products (up 32.9 percent), rubber, plastics, and construction materials (up 32.2 percent), and chemical production (up 22.8 percent).
Food production accounts for about 16 percent of industrial output. The increase in production was driven by a 1.6-fold rise in the output of pasta and soft drinks, as well as a 24.6 percent increase in the production of distilled alcoholic beverages, purification, and blending of spirits.
Pharmaceuticals production boost stands out. In December 2024, Dairbek Orunbekov, head of the Presidential Administration’s Information Policy Service, stressed that over 90 percent of medicines in Kyrgyzstan’s market are imported, making the development of local production critical for meeting domestic demand. In the long run, exports are also being considered, which could further boost the country's GDP.
To support this effort, the state enterprise Kyrgyzpharmacy was established in March 2023 under the Ministry of Health. The company works with investors within humanitarian cooperation and public-private partnerships to expand domestic pharmaceutical production. It also supplies local producers to healthcare facilities and to El-Aman, a network of state-run pharmacies.
Another milestone came late last year, when the government regained ownership of Aidan Pharma , a plant producing 95 percent medical ethanol. Since January 2025, the plant has launched the production of five medicines, including paracetamol, ibuprofen, and acyclovir. By the end of this year, output is expected to expand to more than a hundred types of medicines. With a production capacity of up to 10 thousand packages per day, the facility could become a major supplier on the domestic market.
